Home > News > Biophage Pharma appoints Dr. Pearl Chin to Board of Directors
October 4th, 2005
Biophage Pharma appoints Dr. Pearl Chin to Board of Directors
Biophage Pharma is pleased to announce the appointment of Dr. Pearl Chin to its Board of Directors. Dr.
Chin is the founder and managing Director of Seraphima Ventures, a private equity fund focused on Nanotechnology.
University of Manchester selects Anasys AFM-IR for coatings and corrosion research July 30th, 2014
Nature inspires a greener way to make colorful plastics July 30th, 2014
Analytical solutions from Malvern Instruments support University of Wisconsin-Milwaukee researchers in understanding environmental effects of nanomaterials July 30th, 2014
FEI Unveils New Solutions for Faster Time-to-Analysis in Metals Research July 30th, 2014
ACS Biomaterials Science & Engineering™: Brand-new journal names editor July 29th, 2014
Organometallics welcomes new editor-in-chief: Paul Chirik, Ph.D. July 22nd, 2014
NSS Pays Tribute to Space Pioneer Frederick I. Ordway III July 7th, 2014
Harris & Harris Group Announces Changes to Its Legal Department June 9th, 2014